PRN: US Newborn Screening Market Outlook 2020 - 93% of the newborns are screened for various disorders under the newborn screening test in the US

PRN: US Newborn Screening Market Outlook 2020 - 93% of the newborns are screened for various disorders under the newborn screening test in the US.

Persone Laura Wood, Topics Covered
Luoghi Dublino, Stati Uniti d'America
Organizzazioni Hours, Agilent Technologies Inc.
Argomenti internet, economia, commercio, medicina

23/mar/2016 16:34:19 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

US Newborn Screening Market Outlook 2020 - 93% of the newborns are screened for various disorders under the newborn screening test in the US

 
[22-March-2016]
 

DUBLIN, March 22, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/scrv7d/us_newborn) has announced the addition of the "US Newborn Screening Market Outlook 2020" report to their offering.

The US Newborn Screening market is set to witness several developments in near future. In the new report entitled, US Newborn Screening Market Outlook 2020 the market has been separately studied under tests used for screening, and technologies supporting the diagnosis.

93% of the newborns are screened for various disorders under the newborn screening test in the US. The government is taking various measures to improve the quality and efficiency of these tests. Furthermore, the governments of various states are also engaged in expanding the panel of the tests.

Blood spot test is the most widely performed newborn screening test, followed by hearing screening and Critical Congenital Heart Disease (CCHD) Newborn Screening respectively. The screening technologies used for these tests include tandem mass spectrometry, immunoassays, pulse oximetry, DNA assays and electrophoresis. Immunoassay is the most extensively used technology for newborn screening. The large share of this technology is attributed to the fact that it is a part of primary screening tests for the newborn. Hence, these tests would always witness higher demand.

The report covers developments in the market occurring over the last two years, drivers and challenges controlling the market, and competitive landscape showing prominent players. Factors such as government support through funds, growing awareness, technological advancements and surging genetic disorders are fuelling the growth. On the other hand, lack of uniform regulatory policies in the country and delays in hospital administration are major hurdles of the market.

The study includes prudent analysis of the market size (tests and technologies) for 2014, and forecast till 2020. At the competitive forefront, research has been done at each player including their financials, key products, developments and SWOT analysis. In brief, study presented in the report is likely to generate interest among the potential investors.

Key Topics Covered:

1. Analyst View

2. Research Methodology

3. Newborn Screening - An Introduction

4. Drivers and Challenges

5. US Newborn Screening Market Overview

6. Market Segmentation by Technology

7. Trends and Developments

8. Competitive Assessment

- Agilent Technologies Inc. - Natus Medical - Perkin Elmer - Waters Corporation

For more information visit http://www.researchandmarkets.com/research/scrv7d/us_newborn

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl